Tag Archives: Addyi

Sprout’s female libido drug Addyi back in FDA’s crosshairs years after controversial approval

Sprout Pharmaceuticals’ female libido drug Addyi has traveled a winding path through FDA gatekeepers, multiple M&A deals, marketing restrictions and more. With a possible new safety flag, the controversial medicine could be set for even more scrutiny. In a rundown of potential new safety concerns on approved products, the FDA flagged the Addyi for possible risks of drug hypersensitivity.… Read More »